Eli Lilly launches new version of weight-loss drug Zepbound: a single dose covers a whole month

华尔街见闻2026/02/23 14:11

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

For self-paying patients, the starting price for the entry-level dose on Lilly's direct sales platform, LillyDirect, is only $299 per month. With the explosive growth of Zepbound, Lilly has captured the majority of the weight loss drug market from its competitor Novo Nordisk. In the fourth quarter, Zepbound's revenue in the US reached $4.2 billions, a year-on-year surge of 122%. The US Food and Drug Administration (FDA) has approved the label expansion for Zepbound, incorporating this multi-dose device.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Duan Yongping has made it clear that he will not sell Nvidia and sold a large number of put options on the day the news was released. Nvidia may invite Jensen Huang to serve as an advisor, taking on a “shadow CEO” role to retain his influence, but he would no longer have signing authority. Whether this scenario materializes will likely only become clear after the hearing concludes.

华尔街见闻•2026/11/13 07:48